Why the study?
Offline reinforcement learning approaches face challenges in real-world treatment optimization where suboptimal examples dominate retrospective datasets and strict safety constraints must be satisfied.
Does a transition sampling approach for offline reinforcement learning improve expected health outcomes and guideline consistency in retrospective datasets for diabetes and sepsis treatment optimization?
Does a transition sampling approach for offline reinforcement learning improve expected health outcomes and guideline consistency in retrospective datasets for diabetes and sepsis treatment optimization?
A novel transition sampling approach for offline reinforcement learning improves treatment optimization models for diabetes and sepsis compared to standard baselines.
May enhance offline RL models in retrospective sepsis and diabetes data; leaves open prospective clinical validation.
There is increasing interest in data-driven approaches for recommending optimal treatment strategies in many chronic disease management and critical care applications. Reinforcement learning methods are well-suited to this sequential decision-making problem, but must be trained and evaluated exclusively on retrospective medical record datasets as direct online exploration is unsafe and infeasible. Despite this requirement, the vast majority of treatment optimization studies use off-policy RL methods (e.g., Double Deep Q Networks (DDQN) or its variants) that are known to perform poorly in purely offline settings. Recent advances in offline RL, such as Conservative Q-Learning (CQL), offer a suitable alternative. But there remain challenges in adapting these approaches to real-world applications where suboptimal examples dominate the retrospective dataset and strict safety constraints need to be satisfied. In this work, we introduce a practical and theoretically grounded transition sampling approach to address action imbalance during offline RL training. We perform extensive experiments on two real-world tasks for diabetes and sepsis treatment optimization to compare performance of the proposed approach against prominent off-policy and offline RL baselines (DDQN and CQL). Across a range of principled and clinically relevant metrics, we show that our proposed approach enables substantial improvements in expected health outcomes and in consistency with relevant practice and safety guidelines.
No takes yet. Share an insight, caveat, or question.
Nambiar et al. (2023) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: